Can computers help estimate the quality of cancer cell lines?
In a study funded by Open Targets, Lucia Trastulla and Francesco Iorio discuss the limitations of immortal cancer cell lines (CCLs) to investigate cancer biology in vitro and review the latest computational methods to evaluate the suitability of each CCL as experimental model on a case-by-case basis.
Immortal CCLs are widely adopted models to study cancer biology in vitro and are often used in high-throughput screening for drug discovery. However, misidentification, misclassification, and heterogeneity, as well as usage out of the original in vivo tumour context, not always make CCLs appropriate to translate findings from the bench to the bedside.
Lucia Trastulla and Francesco Iorio at the HT Computational Biology Research Centre, in collaboration with colleagues from the Cancer Dependency Map Project at the Broad Institute, USA, provide an overview of the main limitations of using CCLs as in vitro surrogates for in vivo cancer features and describe how computational methods can be leveraged to identify the best and most representative CCLs depending on the type of primary tumor under investigation. Furthermore, the researchers discuss how machine-learning-based approaches may help reduce discrepancies arising from multi-omics analyses, transfer CCL-based findings to more complex model systems and develop approaches for the realization of personalised medicine.
The review is now published in Molecular Systems Biology.
DOI 10.15252/msb.202211017
Share:
You could also like:
-
HT National Facilities: One Year On, New Call Open
On 10 June, Human Technopole marks the one-year anniversary of the official opening of its National Facilities, a key milestone in our mission to support excellence in life sciences across Italy. Celebrating this important date, we are pleased to announce that the new Call for Access to the National Facilities is now open. Researchers can submit their proposals until 30 September 2025.
-
10 Fully Funded PhD Scholarships in Systems Medicine through SEMM
Human Technopole is offering up to 10 fully funded PhD scholarships through the SEMM PhD Program in Systems Medicine. These scholarships are open to talented and motivated graduates—both from Italy and abroad – interested in pursuing doctoral research.
-
Human Technopole Commitment to Gender Equality
Human Technopole is proud to announce the launch of its new Gender Equality Plan (GEP) for 2025-2027, a strategic initiative designed to further integrate gender equality across all aspects of the Institute, building upon the successful outcomes of the previous GEP (2022-2024). HT has also achieved the UNI/PdR 125:2022 certification, which recognizes organizations that promote gender equality and foster inclusive workplaces.
-
2 fully funded PhD fellowships at HT through SISSA
Human Technopole is offering 2 fully funded 4-year PhD fellowships to young scientists from the national and international community who wish to undertake a doctoral degree on a project focused on Computational Biology.
-
Childhood Cancer: Free DNA in Blood Reveals Therapy Resistance
An international study coordinated by Milan’s Human Technopole, the Institute of Cancer Research (ICR) in London, and the Royal Marsden Hospital in London has shown that certain DNA fragments found in the blood of paediatric cancer patients can be used as “biomarkers” to obtain information on the characteristics of the disease and its ability to resist therapies. Analysing these fragments could represent an effective alternative to tumour tissue biopsy, a practice that is particularly difficult in children.